MODACARE 200

What is MODACARE 200?

MODACARE 200 is a medicinal product in the form of tablets for oral administration, containing the active ingredient modafinil at a dosage of 200 mg. The agent belongs to the pharmacological group of psychostimulants and nootropic drugs that help maintain wakefulness and eliminate pathological daytime sleepiness. The manufacturer of MODACARE 200 is the pharmaceutical company Careclub, which specializes in the production of high-quality products for cognitive function support. In international classification, modafinil is considered an agent affecting the central nervous system, enhancing attention levels and work performance. The drug is used exclusively as prescribed by a physician, as it requires an individual dosage selection and monitoring of the patient's condition.

MODACARE 200 is available as tablets designed in a shape convenient for swallowing and offering an even distribution of the active substance. Each tablet contains a precisely calibrated amount of modafinil, ensuring a predictable therapeutic effect over a prolonged period. The medication belongs to the category of prescription drugs in most countries, as its action is associated with the modulation of brain neurotransmitter systems. The pharmacokinetics of modafinil involve rapid absorption in the gastrointestinal tract, reaching peak plasma concentration approximately two to three hours after ingestion. The elimination half-life is about 12–15 hours, allowing the drug to be taken once daily without a loss of efficacy.

The mechanism of action of MODACARE 200 differs from classic amphetamine-type psychostimulants, as modafinil does not cause pronounced euphoria and possesses a significantly lower potential for abuse. The drug affects the dopaminergic, noradrenergic, and histaminergic systems of the brain, increasing extracellular dopamine levels by blocking its reuptake. This effect provides a sustained sense of alertness, improved concentration, and enhanced mental performance without significant strain on the cardiovascular system. MODACARE 200 by Careclub undergoes strict quality control at all stages of production, guaranteeing compliance with international pharmaceutical safety standards.

What is MODACARE 200 prescribed for?

MODACARE 200 is primarily prescribed for the treatment of narcolepsy — a chronic neurological disorder characterized by overwhelming attacks of daytime sleepiness. Patients with narcolepsy experience sudden loss of muscle tone, hallucinations upon falling asleep, and disrupted nighttime sleep, which significantly reduces quality of life. Modafinil as part of MODACARE 200 helps maintain a stable level of wakefulness during daytime hours, allowing a person to fulfill professional and daily responsibilities without sudden episodes of falling asleep. The therapeutic effect develops gradually and persists throughout the patient's active period.

The second major indication is obstructive sleep apnea syndrome, where the patient suffers from repeated breathing pauses during sleep, leading to chronic sleep deprivation and severe daytime sleepiness. MODACARE 200 is used as an adjunctive agent in the complex therapy of this condition, where the primary treatment is aimed at restoring normal respiration. The drug helps overcome residual sleepiness that persists even after the correction of breathing disorders using specialized devices. This approach enables patients to return to active life and avoid dangerous situations related to falling asleep at the wheel or during work.

MODACARE 200 is also used for shift work sleep disorder, when a person works night shifts or has an irregular sleep schedule. In such cases, the medication helps adapt the body's circadian rhythms to a non-standard schedule, reducing feelings of fatigue and improving cognitive performance during periods when the body normally requires rest. In addition to official indications, modafinil is sometimes used in clinical practice to enhance mental performance in healthy individuals; however, such use requires special caution and medical supervision. The prescription of MODACARE 200 should always be based on a thorough diagnosis and an assessment of the benefit-to-risk ratio for a specific patient.

Composition and active components of MODACARE 200

The main active ingredient of MODACARE 200 is modafinil, a synthetic compound belonging to the class of benzhydrylsulfinylacetamides. Modafinil acts as a selective dopamine reuptake inhibitor, increasing the concentration of this neurotransmitter in the synaptic cleft. Unlike traditional stimulants, modafinil does not cause a sharp release of dopamine, but merely modulates its natural levels, which explains its milder action profile and lower risk of dependence. Additionally, modafinil affects hypothalamic orexin neurons, which play a key role in regulating the sleep-wake cycle. Such a multi-vector mechanism ensures sustained maintenance of alertness without feelings of excessive agitation.

Excipients of MODACARE 200 include microcrystalline cellulose, starch, magnesium stearate, and other pharmaceutically inert substances that ensure tablet stability and uniform release of the active ingredient. These components have no independent pharmacological activity but play an important role in providing proper bioavailability of modafinil. The quality of raw materials used by Careclub is confirmed by certificates of conformity and the results of independent laboratory studies. The manufacturing process is carried out under strict adherence to Good Manufacturing Practice standards, which minimizes the risk of impurities or dosage inconsistencies.

The pharmacological action of MODACARE 200 is realized through simultaneous effects on several neurotransmitter systems, favorably distinguishing it from drugs with a single mechanism of action. Increasing dopamine levels in the prefrontal cortex of the brain improves executive functions, working memory, and sustained concentration ability. Simultaneous activation of histaminergic pathways helps maintain wakefulness, while noradrenaline modulation provides an increase in general body tone. Importantly, the effect of MODACARE 200 develops gradually and is not accompanied by sudden mood swings or euphoria characteristic of other psychostimulants.

Dosage of MODACARE 200

The standard recommended dose of MODACARE 200 for adult patients is 200 mg once daily, preferably in the morning or one hour prior to the start of a work shift. For patients with narcolepsy and obstructive sleep apnea syndrome, the medication is taken in the morning to provide an even therapeutic effect throughout the entire day. In the case of shift work sleep disorder, the tablet is taken approximately one hour before starting the night shift, allowing the body to adapt to the non-standard activity schedule. The physician may adjust the dosage depending on the individual patient's response, age, body weight, and the presence of concomitant diseases.

The maximum daily dose of MODACARE 200 should generally not exceed 400 mg, although for most patients the standard dose of 200 mg is sufficient to achieve the desired clinical effect. Elderly patients may require a dose reduction due to slowed metabolism and increased sensitivity to the action of the drug. The duration of the treatment course is determined individually depending on the nature of the underlying disease and the dynamics of clinical symptoms. In chronic conditions such as narcolepsy, MODACARE 200 can be used long-term under regular medical supervision with periodic evaluation of the therapy's efficacy and safety.

Dose adjustment of MODACARE 200 may be required for patients with impaired hepatic function, as modafinil is metabolized primarily in this organ. In such cases, the physician may recommend reducing the dose by half or increasing the interval between doses. Patients with renal insufficiency typically do not require significant dose adjustment, but require careful monitoring of renal function throughout the treatment period. Self-increasing the dose or frequency of MODACARE 200 intake is strictly discouraged, as it can lead to the development of side effects and increased strain on the cardiovascular system.

How to properly take MODACARE 200?

MODACARE 200 is taken orally, swallowing the tablet with a sufficient amount of water, regardless of food intake. However, it should be kept in mind that taking the drug with fatty food can slow down its absorption and delay the onset of the therapeutic effect by approximately one hour. To achieve maximum efficacy, it is recommended to take MODACARE 200 at the same time every day, which helps establish a stable concentration of the active substance in the blood. The tablet should be swallowed whole, without chewing or crushing, as altering the integrity of the dosage form can affect the release rate of modafinil.

If a patient misses a dose of MODACARE 200, they should take the medication as soon as possible, but no later than 12 hours before the planned bedtime. Taking the drug in the afternoon or evening can cause difficulty falling asleep and disruption of night sleep, which will negate the therapeutic effect of the treatment. Do not double the dose to make up for a missed one, as this increases the risk of side effects without a proportional increase in therapeutic benefit. In case of doubt regarding the dosing regimen, a doctor or pharmacist should be consulted.

During treatment with MODACARE 200, it is important to maintain a healthy sleep and rest schedule, as the drug does not replace full night sleep, but only helps maintain wakefulness during the daytime. Patients are advised to avoid consuming large amounts of caffeinated beverages, as the combination of stimulating effects can cause excessive agitation, anxiety, and heart rhythm disturbances. MODACARE 200 should not be used as a means to completely replace sleep during extended periods of wakefulness, since the body requires recovery through natural physiological mechanisms. If unusual symptoms appear or well-being worsens, drug administration should be discontinued and medical help sought.

Side effects of MODACARE 200

The most common side effects of MODACARE 200 are headaches, which occur in approximately 10–15% of patients at the start of therapy and usually diminish after a few days of intake. Nausea, reduced appetite, dry mouth, and feelings of anxiety or nervousness may also be observed. These symptoms are mostly mild or moderate in nature and do not require discontinuation of the drug, but their occurrence should be reported to the doctor. In most cases, adverse reactions arise in the first weeks of treatment and gradually disappear as the body adapts to the action of modafinil.

Uncommon side effects of MODACARE 200 include tachycardia, elevated blood pressure, palpitations, and chest pain. Patients with pre-existing cardiovascular diseases require special monitoring during treatment, as the stimulating effect on the sympathetic nervous system can provoke exacerbation of existing pathologies. From the nervous system, dizziness, coordination impairment, tremor, and rarely — hallucinations or psychotic reactions may occur. The emergence of any unusual psychiatric symptoms requires immediate discontinuation of the drug and consultation with a doctor.

Rare but serious adverse reactions of MODACARE 200 encompass severe skin reactions, such as Stevens-Johnson syndrome and toxic epidermal necrolysis, which can be life-threatening. If a rash, blisters, skin peeling, or mucosal lesions appear, drug intake must be stopped immediately and emergency medical care sought. Anaphylactic reactions, angioedema, and multi-organ hypersensitivity have also been reported. Individual body reaction to MODACARE 200 can vary significantly, so any deterioration in health during treatment requires professional medical evaluation.

Contraindications of MODACARE 200

MODACARE 200 has absolute contraindications in the presence of which the intake of the drug is strictly prohibited. These include hypersensitivity to modafinil or any excipient of the preparation, which may manifest as allergic reactions of varying severity. Patients with severe cardiovascular diseases, including uncontrolled arterial hypertension, arrhythmias, ischemic heart disease, and recent myocardial infarction, should not use MODACARE 200 due to the risk of serious complications. The drug is also contraindicated in the presence of psychotic disorders, severe anxiety, and agitation, as the stimulating effect may aggravate these conditions.

Special patient groups require increased caution when considering the possibility of using MODACARE 200. Pregnancy is a contraindication to taking the drug, as studies have shown a potential risk of congenital malformations in the fetus. Women of reproductive age are recommended to use reliable methods of contraception during treatment and for two months after its completion. MODACARE 200 is not prescribed to children and adolescents under 18 years of age due to the lack of sufficient data on safety and efficacy in this age group. The period of breastfeeding is also a contraindication, as modafinil passes into breast milk.

Relative contraindications of MODACARE 200 include conditions under which the drug may be used only under strict medical supervision. Patients with a history of epilepsy or seizure disorders have an increased risk of lowered seizure threshold, thus requiring special monitoring during treatment. Individuals with impaired liver and kidney function should receive reduced doses of the drug with regular monitoring of relevant laboratory parameters. Patients with a history of substance abuse require special attention, as modafinil has some potential for developing psychological dependence. Prior to starting MODACARE 200 therapy, a complete medical assessment of the patient's condition and exclusion of all possible contraindications is necessary.

Interaction of MODACARE 200 with other drugs and alcohol

MODACARE 200 can interact with many medications, which necessitates informing the physician about all drugs the patient is taking. Modafinil is an inducer of cytochrome P450 enzymes, particularly the CYP3A4 isoenzyme, leading to accelerated metabolism and reduced efficacy of hormonal contraceptives, cyclosporine, certain antidepressants, and anticoagulants. Concomitant use of MODACARE 200 with warfarin requires more frequent monitoring of blood coagulation parameters, as a decrease in the anticoagulant effect is possible. Drugs metabolized via CYP2C19 may also require dose adjustment when co-administered with modafinil.

The consumption of alcohol during treatment with MODACARE 200 is not recommended, as combining the stimulating effect of modafinil with the depressant effect of ethanol on the central nervous system can lead to unpredictable reactions. Alcohol can mask or worsen the side effects of the drug, increasing the risk of dizziness, impaired coordination, and inadequate assessment of one's condition. Patients taking MODACARE 200 should exercise caution when driving vehicles and operating machinery, especially at the beginning of treatment, until the individual reaction to the drug is established. Despite modafinil improving alertness, in some patients it can cause dizziness or vision disturbances, making driving unsafe.

Where to buy MODACARE 200 in Ukraine

MODACARE 200 is available for purchase in Ukraine through a network of specialized pharmacies and online platforms offering products from Careclub. The drug belongs to the category of prescription medicines, so a valid prescription from a doctor confirming the appropriateness of modafinil use is required to purchase it. This approach ensures patient safety and prevents the uncontrolled use of psychostimulating drugs. When purchasing MODACARE 200, it is important to pay attention to the integrity of the packaging, expiration date, and the presence of protective elements confirming product authenticity.

Storage conditions for MODACARE 200 require keeping the preparation in a dry place, protected from light, at a temperature not exceeding 25 degrees Celsius. Tablets should be stored in their original packaging, out of reach of children, avoiding exposure to high humidity and direct sunlight. The shelf life of the preparation is usually two to three years from the date of manufacture, after which the use of MODACARE 200 is strictly prohibited. Before starting MODACARE 200, it is mandatory to consult a physician to confirm the diagnosis, exclude contraindications, and determine the optimal dosing regimen tailored to individual physiological characteristics.